| Literature DB >> 31759170 |
C Haeseleer1, D Martiny2, Y Van Laethem3, B Cantinieaux4, C Martin3.
Abstract
We describe a symptomatic Plasmodium falciparum infection in a 29-year-old Guinean man receiving Infliximab for one year and without recent travel. The reactivation of submicroscopic malaria following the inhibition of TNF-alpha by infliximab is suspected.Entities:
Keywords: Infliximab; Low parasitemia; Malaria; Non-endemic areas; Reactivation
Mesh:
Substances:
Year: 2019 PMID: 31759170 DOI: 10.1016/j.ijid.2019.11.016
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 3.623